GM23375
LCL from B-Lymphocyte
Description:
DYSTROPHIA MYOTONICA 1; DM1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Ethnicity
|
IRAQI
|
Family Member
|
2
|
Family History
|
N
|
Relation to Proband
|
son
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
DMPK |
Chromosomal Location |
19q13.2-q13.3 |
Allelic Variant 1 |
605377.0001; MYOTONIC DYSTROPHY |
Identified Mutation |
(CTG)n EXPANSION; The consistent genetic defect associated with myotonic dystrophy is an amplified trinucleotide CTG repeat in the 3-prime untranslated region of the serine-threonine kinase gene DMK on 19q. Unaffected individuals have between 5 and 27 copies. DM patients who are minimally affected have at least 50 repeats, while more severely affected patients have expansion of the repeat-containing segment up to several kilobases. |
Remarks |
Clinically affected; affected mother is GM23358; using ankle brace at age 1 year; on ventilator for four weeks after birth; difficulty swallowing; facial weakness; donor subject has one normal CTG repeat allele and one allele with a CTG repeat size of approximately 1700-1800 in the DMPK gene |
NCBI GTR |
160900 MYOTONIC DYSTROPHY 1; DM1 |
OMIM |
160900 MYOTONIC DYSTROPHY 1; DM1 |
Omim Description |
DM PROTEIN KINASE, INCLUDED |
|
DYSTROPHIA MYOTONICA; DM |
|
DYSTROPHIA MYOTONICA; DMPK |
|
MYOTONIC DYSTROPHY |
|
MYOTONIC DYSTROPHY PROTEIN KINASE, INCLUDED; MDPK, INCLUDED |
|
MYOTONIN-PROTEIN KINASE, INCLUDED |
|
STEINERT DISEASEDM-KINASE, INCLUDED; DMK, INCLUDED |
Split Ratio |
1:4 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|